theMednetRegister

Psychiatry

Addiction Psychiatry   

Questions discussed in this category

What recommendations do you have regarding the use of dronabinol to prevent cannabis withdrawal in an inpatient medical or psychiatric setting?
1 Answer available
How do you counsel patients on vaping cessation as compared to smoking cessation?
Is there evidence for the use of varenicline, bupropion, or other medication therapies to assist in tobacco vaping cessation?
1 Answer available
When do you recommend acamprosate vs naltrexone for medication-assisted therapy in alcohol use disorder?
2 Answers available
How do you approach the use of buprenorphine/naloxone in pregnant and breastfeeding patients?
In light of Straub et al's comparative study of combination vs buprenorphine alone
1 Answer available
What precautions should be taken when discharging a patient from the medical setting on new medication assisted therapy for alcohol use disorder?
This is based on the recent publication by Bernstein et al., PMID 38551564 which investigated the increased rate of initiation of MAUD in the hospital...
1 Answer available
How do you approach switching from methadone to buprenorphine/naloxone for patients who want to change medication management for opioid use disorder?
1 Answer available
In what cases do you recommend the use of gabapentin for off-label use in alcohol use disorder?
3 Answers available
How do you approach pain management needs for patients well-established on buprenorphine/naloxone?
1 Answer available
In what cases do you use baclofen for alcohol use disorder?
2 Answers available


Papers discussed in this category

JAMA internal medicine, 2019 Oct 01
Acute Pain Management in Patients Treated With Buprenorphine: A Teachable Moment.
Frontiers in psychiatry, 2018 Oct 08
Tailored-Dose Baclofen in the Management of Alcoholism: A Retrospective Study of 144 Outpatients Followed for 3 Years in a French General Practice.
Pharmacoepidemiology and drug safety, 2018 Sep 25
Risk of hospitalisation and death related to baclofen for alcohol use disorders: Comparison with nalmefene, acamprosate, and naltrexone in a cohort study of 165 334 patients between 2009 and 2015 in France.
The Journal of clinical psychiatry, 2020 Aug 04
Individualized, High-Dose Baclofen for Reduction in Alcohol Intake in Persons With High Levels of Consumption.

Related Topics in Psychiatry

Copyright © 2024 theMednet
All Rights Reserved.